title: How are prostaglandins and leukotrienes involved in immunological alterations?
mesh_terms: D000818:Animals; D001095:Arachidonic Acids / Q000276:immunology / Q000502:physiology; D001241:Aspirin / Q000627:therapeutic use; D002056:Burns / Q000188:drug therapy / Q000276:immunology*; D002463:Cell Membrane Permeability; D015232:Dinoprostone; D004804:Eosinophils / Q000276:immunology; D005609:Free Radicals; D006801:Humans; D007249:Inflammation / Q000276:immunology; D007975:Leukotriene B4 / Q000276:immunology*; D009504:Neutrophils / Q000276:immunology; D011453:Prostaglandins / Q000276:immunology*; D011458:Prostaglandins E / Q000276:immunology; D011971:Receptors, Immunologic / Q000276:immunology; D018102:Receptors, Leukotriene B4; D013189:SRS-A / Q000276:immunology*; D012867:Skin / Q000098:blood supply / Q000276:immunology; D013256:Steroids / Q000627:therapeutic use; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors
chemical_list: D001095:Arachidonic Acids; D005609:Free Radicals; D011453:Prostaglandins; D011458:Prostaglandins E; D011971:Receptors, Immunologic; D018102:Receptors, Leukotriene B4; D013189:SRS-A; D013256:Steroids; D007975:Leukotriene B4; D013930:Thromboxane-A Synthase; D015232:Dinoprostone; D001241:Aspirin